Description

🖼️ Tool Name:
Tierra Biosciences

🔖 Tool Category:
AI-driven synthetic biology / cell-free protein synthesis platform; falls under the category of biotech/MedTech tools that use AI and automated systems to produce and optimise proteins.

✏️ What does this tool offer?
Tierra Biosciences provides a platform (the “Tierra Protein Platform”) that allows clients to submit protein sequences and then uses high-throughput, cell-free synthetic biology + AI to produce and characterise those proteins much faster than traditional cell-based methods.
Key features:

  • Cell-free systems covering gram-positive, gram-negative and eukaryotic species to express proteins outside living cells.

  • AI models trained on large datasets of protein sequence → expression/behaviour to predict manufacturability and performance.

  • Online portal where users upload sequences, the platform assesses manufacturability, then synthesises DNA, expresses protein, purifies it, and ships it to the customer.

What does the tool actually deliver based on user experience?
• Clients can go from sequence submission to “purified proteins ready for downstream use” in a much shorter time compared to traditional methods.
• Enables rapid iteration of protein variants (hundreds at a time) which helps in design-build-test-learn workflows. 
• Generates large datasets of protein expression and behaviour (solubility, stability, yield) which in turn improve the AI models. 

🤖 Does it include automation?
Yes — Tierra’s platform is highly automated:
• Automated DNA assembly, codon optimisation and cell-free expression pipelines. 
• AI-driven sequence assessment to predict whether a protein is likely manufacturable or requires redesign. 
• Automated, high-throughput production (cell-free systems and robotic handling) enabling hundreds of proteins processed in parallel. 

💰 Pricing Model:
Not publicly detailed — the model appears to be B2B / service-based: clients pay for custom protein synthesis and data services. The company has raised funding (Series A) to scale. 

🆓 Free Plan Details:
No indication of a free public plan; this is an enterprise / research-service platform rather than a consumer SaaS with freemium tier.

💳 Paid Plan Details:
Paid service: clients order bespoke proteins, which involves cost for synthesis, expression, purification and data. Pricing likely depends on scale, complexity and customisation.

🧭 Access Method:
• Web portal: clients submit sequences via Tierra’s website.
• Partnerships with pharma, biotech, agriculture, industrial biotech sectors. 

🔗 Experience Link:

https://www.tierrabiosciences.com

Pricing Details

💰 Pricing Model: Not publicly detailed — the model appears to be B2B / service-based: clients pay for custom protein synthesis and data services. The company has raised funding (Series A) to scale.  🆓 Free Plan Details: No indication of a free public plan; this is an enterprise / research-service platform rather than a consumer SaaS with freemium tier. 💳 Paid Plan Details: Paid service: clients order bespoke proteins, which involves cost for synthesis, expression, purification and data. Pricing likely depends on scale, complexity and customisation.